Structure-based discovery of LpxC inhibitors

被引：18

作者：

Zhang, Jing ^{[1
]}

Chan, Audrey ^{[1
]}

Lippa, Blaise ^{[1
]}

Cross, Jason B. ^{[1
]}

Liu, Christopher ^{[1
]}

Yin, Ning ^{[1
]}

Romero, Jan Antoinette C. ^{[1
]}

Lawrence, Jonathan ^{[1
]}

Heney, Ryan ^{[1
]}

Herradura, Prudencio ^{[1
]}

Goss, Jennifer ^{[1
]}

Clark, Cynthia ^{[1
]}

Abel, Cassandra ^{[1
]}

Zhang, Yanzhi ^{[1
]}

Poutsiaka, Katherine M. ^{[1
]}

Epie, Felix ^{[1
]}

Conrad, Mary ^{[1
]}

Mahamoon, Azard ^{[1
]}

Kien Nguyen ^{[1
]}

Chavan, Ajit ^{[1
]}

Clark, Edward ^{[1
]}

Li, Tong-chuan ^{[1
]}

Cheng, Robert K. ^{[2
]}

Wood, Michael ^{[2
]}

Andersen, Ole A. ^{[2
]}

Brooks, Mark ^{[2
]}

Kwong, Jason ^{[2
]}

Barker, John ^{[2
]}

Parr, Ian Barrie ^{[1
]}

Gu, Yugui ^{[1
]}

Ryan, M. Dominic ^{[1
]}

Coleman, Scott ^{[1
]}

Metcalf, Chester A., III ^{[1
]}

机构：

[1] Cubist Pharmaceut Inc, 65 Hayden Ave, Lexington, MA 02421 USA

[2] Evotec UK Ltd, 114 Innovat Dr,Milton Pk, Abingdon OX14 4RZ, Oxon, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2017年 / 27卷 / 08期

关键词：

LpxC; Escherichia coli; Klebsiella pneumonia; Pseudomonas aeruginosa; Acinetobacter baumannii; Antibacterial; ZINC-DEPENDENT DEACETYLASE; CRYSTAL-STRUCTURE; MECHANISM; ESKAPE;

D O I：

10.1016/j.bmcl.2017.03.006

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The emergence and spread of multidrug-resistant (MDR) Gram negative bacteria presents a serious threat for public health. Novel antimicrobials that could overcome the resistance problems are urgently needed. UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) is a cytosolic zinc-based deacetylase that catalyzes the first committed step in the biosynthesis of lipid A, which is essential for the survival of Gram-negative bacteria. Our efforts toward the discovery of novel LpxC inhibitors are presented herein. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：1670 / 1680

页数：11

共 18 条

[1]

[Anonymous], ANT RES THREATS US

[2]

Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9

[3] Uridine-Based Inhibitors as New Leads for Antibiotics Targeting Escherichia coli LpxC [J].

Barb, Adam W. ;

Leavy, Tanya M. ;

Robins, Lori I. ;

Guan, Ziqiang ;

Six, David A. ;

Zhou, Pei ;

Bertozzi, Carolyn R. ;

Raetz, Christian R. H. .

BIOCHEMISTRY, 2009, 48 (14) :3068-3077

[4] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].

Boucher, Helen W. ;

Talbot, George H. ;

Bradley, John S. ;

Edwards, John E., Jr. ;

Gilbert, David ;

Rice, Louis B. ;

Scheld, Michael ;

Spellberg, Brad ;

Bartlett, John .

CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12

[5] Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections [J].

Brown, Matthew F. ;

Reilly, Usa ;

Abramite, Joseph A. ;

Arcari, Joel T. ;

Oliver, Robert ;

Barham, Rose A. ;

Che, Ye ;

Chen, Jinshan Michael ;

Collantes, Elizabeth M. ;

Chung, Seung Won ;

Desbonnet, Charlene ;

Doty, Jonathan ;

Doroski, Matthew ;

Engtrakul, Juntyma J. ;

Harris, Thomas M. ;

Huband, Michael ;

Knafels, John D. ;

Leach, Karen L. ;

Liu, Shenping ;

Marfat, Anthony ;

Marra, Andrea ;

McElroy, Eric ;

Melnick, Michael ;

Menard, Carol A. ;

Montgomery, Justin I. ;

Mullins, Lisa ;

Noe, Mark. C. ;

O'Donnell, John ;

Penzien, Joseph ;

Plummer, Mark S. ;

Price, Loren M. ;

Shanmugasundaram, Veerabahu ;

Thoma, Christy ;

Uccello, Daniel P. ;

Warmus, Joseph S. ;

Wishka, Donn G. .

JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) :914-923

[6] Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine:: Insights into the mechanism and inhibitor design [J].

Coggins, BE ;

McClerren, AL ;

Jiang, L ;

Li, XC ;

Rudolph, J ;

Hindsgaul, O ;

Raetz, CRH ;

Zhou, P .

BIOCHEMISTRY, 2005, 44 (04) :1114-1126

[7] Structure of the Metal-Dependent Deacetylase LpxC from Yersinia enterocolitica Complexed with the Potent Inhibitor CHIR-090 [J].

Cole, Kathryn E. ;

Gattis, Samuel G. ;

Angell, Heather D. ;

Fierke, Carol A. ;

Christianson, David W. .

BIOCHEMISTRY, 2011, 50 (02) :258-265

[8] A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466 [J].

Cuny, Gregory D. .

EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (06) :893-899

[9]

Grayson ML, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P2

[10] Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold [J].

Liang, Xiaofei ;

Lee, Chul-Jin ;

Chen, Xin ;

Chung, Hak Suk ;

Zeng, Daina ;

Raetz, Christian R. H. ;

Li, Yaoxian ;

Zhou, Pei ;

Toone, Eric J. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (02) :852-860

← 1 2 →